Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Asaka N et al. Effects of the new benzimidazole derivative TAS-203, an orally active phosphodiesterase 4 inhibitor, on airway inflammation in rats and emetic responses in ferrets. 2010 Arzneimittelforschung pmid:21117500
Tsunoda H et al. Activity of a novel thienodiazepine derivative as a platelet-activating factor antagonist in guinea pig lungs. Effects on platelet-activating factor and allergen induced eosinophil accumulation. 1991 Arzneimittelforschung pmid:1867658
Giudice A et al. Prevention of platelet-activating factor-induced gastrointestinal lesions in rats by the new specific antagonist N-(2-dimethylaminoethyl)-N-(3-pyridinylmethyl)[4-(2,4,6-triisopropylphe nyl) thiazol-2yl]amine. 1996 Arzneimittelforschung pmid:8740089
Cheung HT et al. Inhibition of platelet aggregation by diterpene acids from Pinus massoniana resin. 1994 Arzneimittelforschung pmid:8135873
David S et al. Production of platelet activating factor by human neutrophils after backfiltration of endotoxin contaminated dialysate. 1993 Jul-Sep ASAIO J. pmid:8268642
Takayama K et al. Changes in endothelial vasoactive substances under recombinant human erythropoietin therapy in hemodialysis patients. 1991 Jul-Sep ASAIO Trans pmid:1836334
Akizawa T et al. Endothelin and platelet activating factor. Possible indices for biocompatibility of hemodialysis. 1991 Jul-Sep ASAIO Trans pmid:1751199
Ando M et al. Pregnancy suppression by a platelet activating factor antagonist, ONO-6240, in mice. 1990 Asia Oceania J Obstet Gynaecol pmid:2378595
Ando M et al. Pregnancy suppression by a structurally related antagonist for platelet activating factor, CV-6209, in mice. 1990 Asia Oceania J Obstet Gynaecol pmid:2088253
Roudebush WE Role of platelet-activating factor in reproduction: sperm function. 2001 Asian J. Androl. pmid:11404790
Tsai JJ et al. The modulatory effect of antigen- and PAF-induced asthmatic reaction by aerosol administration of OKY-046 in guinea pigs. 1995 Asian Pac. J. Allergy Immunol. pmid:8703249
Tsai JJ et al. Enhanced eosinophil luminol-dependent chemiluminescence and complement receptor expression by platelet-activating factor and interleukin-5. 1993 Asian Pac. J. Allergy Immunol. pmid:8216559
Tselepis AD and John Chapman M Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor-acetylhydrolase. 2002 Atheroscler Suppl pmid:12573364
Feliste R et al. Protective effect of BN 52021, a specific antagonist of platelet-activating factor (PAF-acether) against diet-induced cholesteryl ester deposition in rabbit aorta. 1989 Atherosclerosis pmid:2783199
Caslake MJ et al. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase: a potential new risk factor for coronary artery disease. 2000 Atherosclerosis pmid:10856534
Mügge A et al. Activation of leukocytes with complement C5a is associated with prostanoid-dependent constriction of large arteries in atherosclerotic monkeys in vivo. 1992 Atherosclerosis pmid:1418094
Verouti SN et al. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects. 2011 Atherosclerosis pmid:21920519
Fiotti N et al. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 1999 Atherosclerosis pmid:10428295
Croft KD et al. Leukocyte and platelet function and eicosanoid production in subjects with hypercholesterolaemia. 1990 Atherosclerosis pmid:2173612
Violi F et al. Inhibition of cyclooxygenase-independent platelet aggregation by low vitamin E concentration. 1990 Atherosclerosis pmid:2115784
Deigner HP et al. Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes. 1999 Atherosclerosis pmid:10381281
Hasselwander O et al. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. 1999 Atherosclerosis pmid:10208487
Bochkov VN et al. Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins. 1992 Atherosclerosis pmid:1334652
Imaizumi T et al. Effect of cigarette smoking on the levels of platelet-activating factor-like lipid(s) in plasma lipoproteins. 1991 Atherosclerosis pmid:1872924
Yamada Y et al. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population. 2000 Atherosclerosis pmid:10781653
Pégorier S et al. Oxidized phospholipid: POVPC binds to platelet-activating-factor receptor on human macrophages. Implications in atherosclerosis. 2006 Atherosclerosis pmid:16386258
Tiniakou I et al. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice. 2015 Atherosclerosis pmid:26363436
Narita S and Asakura K The effects of anti-PAF and other agents on the nasal symptoms in sensitized guinea pigs. 1993 Auris Nasus Larynx pmid:7905260
Tachibana F et al. Platelet-activating factor and leukotrienes in acute otitis media, secretory otitis media, and chronic otitis media on the acute excerbation. 1996 Auris Nasus Larynx pmid:8809319
Ogura M et al. Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. 2008 Auris Nasus Larynx pmid:17997066
Morley J Asthma mortality and inhaled beta agonist therapy. 1992 Aust N Z J Med pmid:1359864
Jackson SP and Salem HH Platelet aggregating activity in the plasma of patients with established thrombosis. 1989 Aust N Z J Med pmid:2504137
Gillin AG Maintenance of high risk pregnancies: role of prostaglandins and other mediators. 1994 Aust N Z J Obstet Gynaecol pmid:7848215
Klopper A and Saunders DM Signals from the conceptus. 1994 Aust N Z J Obstet Gynaecol pmid:7531434
Cooper TM and Ingram DM Platelet function in the peri-operative period. 1991 Aust N Z J Surg pmid:1829351
Jobe LW et al. Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730. 1993 Autoimmunity pmid:8025205
Beck JC et al. Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat. 1991 Autoimmunity pmid:1777555
Jauchem JR The role of autacoids and the autonomic nervous system in cardiovascular responses to radio-frequency energy heating. 2006 Auton Autacoid Pharmacol pmid:16553641
Subbotina LA [Procedure of blood agregation system analysis]. 2006 Sep-Oct Aviakosm Ekolog Med pmid:17357632
Brady M et al. Cytokines and acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030606
Imrie CW and McKay CJ The possible role of platelet-activating factor antagonist therapy in the management of severe acute pancreatitis. 1999 Baillieres Best Pract Res Clin Gastroenterol pmid:11030612
Harper MJ The implantation window. 1992 Baillieres Clin Obstet Gynaecol pmid:1424330
Ahmed AS and Smith SK The endometrium: prostaglandins and intracellular signalling at implantation. 1992 Baillieres Clin Obstet Gynaecol pmid:1335852
O'Neill C A consideration of the factors which influence and control the viability and developmental potential of the preimplantation embryo. 1991 Baillieres Clin Obstet Gynaecol pmid:1855338
Smith SK The role of prostaglandins in implantation. 1991 Baillieres Clin Obstet Gynaecol pmid:1855344
Bonney RC and Franks S The endocrinology of implantation and early pregnancy. 1990 Baillieres Clin. Endocrinol. Metab. pmid:1701083
Pearson JD The control of production and release of haemostatic factors in the endothelial cell. 1993 Baillieres Clin. Haematol. pmid:8025346
Ranasinghe S and Bolsover S Microglial calcium responses to platelet-activating factor are inhibited by analogue CAS 99103-16-9 and dihydropyridine PCA 4248 but not by ginkgolide A. 2004 Basic Clin. Pharmacol. Toxicol. pmid:15379786
Chu WF et al. Increasing Intracellular calcium of guinea pig ventricular myocytes induced by platelet activating factor through IP3 pathway. 2006 Basic Clin. Pharmacol. Toxicol. pmid:16433899
Droy-Lefaix MT et al. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. 1988 Basic Life Sci. pmid:3250539
Colton CA and Gilbert DL An endogenous source of the superoxide anion in the central nervous system. 1988 Basic Life Sci. pmid:2854971
Fiedler VB et al. Comparison of cardiac and hemodynamic effects of platelet-activating factor-acether and leukotriene D4 in anesthetized dogs. 1987 Mar-Apr Basic Res. Cardiol. pmid:3606544
Napoli C et al. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein. 1997 Basic Res. Cardiol. pmid:9166989
Auchampach JA et al. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function. 1998 Basic Res. Cardiol. pmid:9833148
Felix SB et al. Cardiovascular reactions and respiratory events during platelet activating factor-induced shock. 1990 May-Jun Basic Res. Cardiol. pmid:2383216
Leprán I and Lefer AM Ischemia aggravating effects of platelet-activating factor in acute myocardial ischemia. 1985 Mar-Apr Basic Res. Cardiol. pmid:4039929
Giessler C et al. Effects of PAF on cardiac function and eicosanoid release in the isolated perfused rat heart: comparison between normotensive and spontaneously hypertensive rats. 1995 Jul-Aug Basic Res. Cardiol. pmid:8534259
Saraf MK et al. Role of platelet activating factor in triazolobenzodiazepines-induced retrograde amnesia. 2003 Behav. Brain Res. pmid:12798263
Jerusalinsky D et al. Effect of antagonists of platelet-activating factor receptors on memory of inhibitory avoidance in rats. 1994 Behav. Neural Biol. pmid:7945139
Ichinose M et al. Activation of K+ current in macrophages by platelet activating factor. 1992 Biochem. Biophys. Res. Commun. pmid:1370616
Smith RJ et al. Effects of an anion channel blocker, 4, 4'-diisothiocyano-2,2'-disulfonic acid stilbene (DIDS), on human neutrophil function. 1984 Biochem. Biophys. Res. Commun. pmid:6329191
Dillon AM and Heath MF The effects of tyrphostins B42 and B46 on equine platelet function and protein tyrosine phosphorylation. 1995 Biochem. Biophys. Res. Commun. pmid:7542881
Doebber TW et al. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. 1985 Biochem. Biophys. Res. Commun. pmid:2985058
Pfeilschifter J et al. Inhibition of renin secretion by platelet activating factor (acetylglyceryl ether phosphorylcholine) in cultured rat renal juxtaglomerular cells. 1985 Biochem. Biophys. Res. Commun. pmid:2985064
Lerner R et al. Platelet activating factor and leukotriene B4 induce hyperpolarization of human endothelial cells but depolarization of neutrophils. 1988 Biochem. Biophys. Res. Commun. pmid:2838025
Hwang SB et al. Specific binding sites for platelet activating factor in human lung tissues. 1985 Biochem. Biophys. Res. Commun. pmid:2986633
Clay KL et al. Structure elucidation of platelet activating factor derived from human neutrophils. 1984 Biochem. Biophys. Res. Commun. pmid:6430285
Blank ML et al. Generation of the precursor (lyso-PAF) of platelet-activating factor via a CoA-dependent transacylase. 1995 Biochem. Biophys. Res. Commun. pmid:7763233
Tokumura A et al. Evidence for existence of various homologues and analogues of platelet activating factor in a lipid extract of bovine brain. 1987 Biochem. Biophys. Res. Commun. pmid:3593346
Kojima S et al. Cooperativity between platelet-activating factor and collagen in platelet aggregation. 1987 Biochem. Biophys. Res. Commun. pmid:3593379
Lad PM et al. Platelet-activating factor mediated effects on human neutrophil function are inhibited by pertussis toxin. 1985 Biochem. Biophys. Res. Commun. pmid:2990462
Comminges C et al. Differential labelings suggest two specific phospholipid subclass hydrolysis promoted by PDGF-BB in vascular smooth muscle cells. 1996 Biochem. Biophys. Res. Commun. pmid:8607782
Weber C et al. Platelet activating factor enhances receptor-operated Ca(++)-influx and subsequent prostacyclin synthesis in human endothelial cells. 1993 Biochem. Biophys. Res. Commun. pmid:8373423
Resink TJ et al. The influence of activating hormones on human platelet membrane Ca2+-ATPase activity. 1986 Biochem. Biophys. Res. Commun. pmid:2943273
White GC Effect of 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine on calcium fluxes by human platelet microsomes. 1984 Biochem. Biophys. Res. Commun. pmid:6428395
Schlondorff D et al. Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells. 1986 Biochem. Biophys. Res. Commun. pmid:3099783
Satouchi K et al. Evidence for production of 1-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine concomitantly with platelet-activating factor. 1985 Biochem. Biophys. Res. Commun. pmid:4004866
Carveth HJ et al. Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. 1989 Biochem. Biophys. Res. Commun. pmid:2665743
Shukla SD and Hanahan DJ AGEPC (platelet activating factor) induced stimulation of rabbit platelets: effects on phosphatidylinositol, di- and triphosphoinositides and phosphatidic acid metabolism. 1982 Biochem. Biophys. Res. Commun. pmid:6288030
Kok PT et al. Arachidonic acid can induce leukotriene C4 formation by purified human eosinophils in the absence of other stimuli. 1988 Biochem. Biophys. Res. Commun. pmid:3132917
Nogami M et al. The effect of platelet-activating factor on [14C]aminopyrine uptake by isolated guinea pig parietal cells. 1990 Biochem. Biophys. Res. Commun. pmid:2346478
Kojima S et al. Cooperativity between platelet-activating factor and collagen in aggregation of bovine platelets, II. 1990 Biochem. Biophys. Res. Commun. pmid:2346486
Silva-Neto MA et al. Platelet-activating factor (PAF) activates casein kinase 2 in the protozoan parasite Herpetomonas muscarum muscarum. 2002 Biochem. Biophys. Res. Commun. pmid:12054663
Palmantier R et al. Biosynthesis of paf-acether. XIV. Paf-acether output in murine peritoneal macrophages is regulated by the level of acetylhydrolase. 1989 Biochem. Biophys. Res. Commun. pmid:2751666
Filep J et al. Increased levels of platelet-activating factor in blood following intestinal ischemia in the dog. 1989 Biochem. Biophys. Res. Commun. pmid:2916986
Rigat B et al. GM2 activator protein inhibits platelet activating factor signaling in rats. 2009 Biochem. Biophys. Res. Commun. pmid:19486886
Kato T et al. Augmentation of DNA synthesis in guinea pig bone marrow cells by platelet-activating factor (PAF). 1988 Biochem. Biophys. Res. Commun. pmid:3202869
Takayasu M et al. Endothelin-induced mobilization of Ca2+ and the possible involvement of platelet activating factor and thromboxane A2. 1989 Biochem. Biophys. Res. Commun. pmid:2655596
Domingo MT et al. Presence of specific binding sites for platelet-activating factor (PAF) in brain. 1988 Biochem. Biophys. Res. Commun. pmid:2831903
Iwamoto S et al. Platelet microparticles: a carrier of platelet-activating factor? 1996 Biochem. Biophys. Res. Commun. pmid:8579618
Rigat B et al. The GM2 activator protein, a novel inhibitor of platelet-activating factor. 1999 Biochem. Biophys. Res. Commun. pmid:10329374
Inui H et al. Participation of diacylglycerol kinase in mitogenic signal transduction induced by platelet-derived growth factor in vascular smooth muscle cells. 1994 Biochem. Biophys. Res. Commun. pmid:7802667
Hartiala KT et al. Lack of correlation between calcium mobilization and respiratory burst activation induced by chemotactic factors in rabbit polymorphonuclear leukocytes. 1987 Biochem. Biophys. Res. Commun. pmid:3034265
Chau LY et al. Photoaffinity labeling of platelet activating factor binding sites in rabbit platelet membranes. 1989 Biochem. Biophys. Res. Commun. pmid:2545193
Smith RJ and Bowman BJ Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism. 1982 Biochem. Biophys. Res. Commun. pmid:6803804
Ye RD et al. Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. 1991 Biochem. Biophys. Res. Commun. pmid:1656963
Nishinaka Y et al. A new sensitive chemiluminescence probe, L-012, for measuring the production of superoxide anion by cells. 1993 Biochem. Biophys. Res. Commun. pmid:8390246
Combadière C et al. Staurosporine, a protein kinase inhibitor, up-regulates the stimulation of human neutrophil respiratory burst by N-formyl peptides and platelet activating factor. 1990 Biochem. Biophys. Res. Commun. pmid:2158320
Shiono S et al. Neurotransmitter release from lysophosphatidic acid stimulated PC12 cells: involvement of lysophosphatidic acid receptors. 1993 Biochem. Biophys. Res. Commun. pmid:8390248
Prevost MC et al. Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia. 1984 Biochem. Biophys. Res. Commun. pmid:6422938